文献速递乳腺癌放疗

缩小乳腺癌种族差异:影响辅助放疗概率的因素

Narrowing Racial Gaps in Breast Cancer: Factors Affecting Probability of Adjuvant Radiation Therapy.
PubMed 文献 · Adv Radiat Oncol · 2019-08-16

该前瞻性研究纳入华盛顿特区和密歇根州底特律地区2006年7月至2011年4月招募的原发性浸润性非转移性乳腺癌女性,分析社会文化、心理社会及医疗保健因素与辅助放疗使用的关系。在217例符合辅助乳腺或胸壁放疗标准的女性中,约70%接受了辅助放疗;多变量分析显示,任何放疗指征的黑人女性接受辅助放疗的可能性更高(OR 2.21;P < .01),且自效能和提供者沟通等积极社会文化因素与放疗接受相关(OR 1.20;P < .05)。

要点

  • 任何放疗指征的黑人女性接受辅助放疗的可能性高于白人(OR 2.21;P < .01)。
  • 自效能和提供者沟通等积极社会文化因素与辅助放疗接受相关(OR 1.20;P < .05)。
  • 在放疗指征强烈的女性中,多变量分析未发现种族与放疗接受显著相关。

核心结论

  • 在有任何放疗指征的女性中,黑人患者接受辅助放疗的可能性高于白人患者。
  • 提供者沟通改善和自效能是接受辅助放疗的重要预测因素。

研究设计与样本

  • 前瞻性研究,2006年7月至2011年4月从华盛顿特区和密歇根州底特律地区医院及社区招募原发性浸润性非转移性乳腺癌女性。
  • 通过电话访谈收集诊断时的心理社会(如自效能)和医疗保健因素(如沟通)数据,治疗完成后从病历提取临床数据。
  • 395例符合条件并同意参与的女性中,315例有完整基线数据,217例符合乳腺保守手术或乳房切除术后辅助乳腺或胸壁放疗标准并纳入最终分析样本。

主要发现

  • 符合放疗条件的女性均享有保险,59%为黑人,平均年龄55.4岁,多数为I或II期疾病。
  • 总体约70%的女性接受了辅助放疗。
  • 多变量分析中,任何放疗指征的黑人女性接受辅助放疗的可能性更高(OR 2.21;P < .01)。
  • 存在合并症以及自效能和提供者沟通报告率高的积极社会文化因素与辅助放疗接受相关(OR 1.20;P < .05)。
  • 在放疗指征强烈的女性中,多变量分析未发现种族与放疗接受显著相关。

关键数值与推荐

  • 辅助放疗接受率:总体约70%。
  • 任何放疗指征的黑人女性接受辅助放疗的OR为2.21(P < .01)。
  • 自效能和提供者沟通等积极社会文化因素与放疗接受的OR为1.20(P < .05)。

临床怎么用

  • 在临床中应重视提供者与患者关于放疗的沟通,并关注患者自效能等社会文化因素。
  • 对于有任何放疗指征的乳腺癌患者,不应基于种族预设其放疗接受可能性。

局限性

  • 最终分析样本量较小(217例),可能影响统计效能和结果外推。
  • 研究仅纳入享有保险的女性,可能限制结论对其他人群的适用性。
  • 数据来自特定地区(华盛顿特区和底特律)和特定时间段(2006-2011年),存在地域和时间局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Adjuvant radiation therapy has historically been underused by black patients with breast cancer compared with white patients. We prospectively investigated factors, including sociocultural, psychosocial, and health care factors, that may be associated with the use or omission of adjuvant radiation therapy by both racial groups. METHODS AND MATERIALS: Women with primary invasive, nonmetastatic breast cancer were recruited from hospitals and through community outreach efforts in the Washington, DC, and Detroit, Michigan, areas between July 2006 and April 2011. Data were collected via telephone interviews regarding psychosocial (eg, self-efficacy) and health care factors (eg, communication) at the time they received a diagnosis. Clinical data were extracted from their medical charts after the completion of treatment. We examined the association among multiple demographic, socio-cultural, healthcare process factors and the use of radiotherapy. Logistic multivariable regression models identified associations with radiotherapy receipt. RESULTS: Among 395 eligible and consenting women, 315 had complete baseline data, and 217 were in the final analytical sample, having met criteria for adjuvant breast or chest wall radiation therapy after breast conservation surgery or mastectomy. Among women eligible for radiation, all were insured, 59% were black, the mean age was 55.4 years, and the majority had stage I or II disease. Overall, approximately 70% percent of women received adjuvant radiation therapy. On multivariable analyses, the likelihood of receiving adjuvant radiation therapy was higher for those who were black with any level of indication for radiation therapy (odds ratio 2.21; P < .01), those for whom comorbidities were present, and those who demonstrated positive sociocultural factors such as self-efficacy and high reported rates of provider communication about radiation therapy (odds ratio 1.20; P < .05). Among women with strong indications for radiation therapy, there was no significant association with race on multivariable analysis. CONCLUSIONS: Our findings suggest that among women with any indication for radiation therapy, black patients were more likely to receive radiation therapy compared with white patients. Furthermore, data suggest improved provider communication and self-efficacy are important predictors of receipt of radiation therapy. Further studies exploring the effects of provider communication and sociocultural factors to diverse patient populations may be warranted.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Snead F, Slade AN, Oppong BA, et al. Narrowing Racial Gaps in Breast Cancer: Factors Affecting Probability of Adjuvant Radiation Therapy. Adv Radiat Oncol. 2019. PMID: 32051886. doi:10.1016/j.adro.2019.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。